Action of botulinum neurotoxins in the central nervous system: Antiepileptic effects

Neurotoxicity Research

Volumn 9, Issue 2-3, 2006, Pages 197-203

  Bozzi, Yuri ^a   Costantin, Laura ^b   Antonucci, Flavia ^a   Caleo, Matteo ^a  

^a CNR Consiglio Nazionale delle Ricerche   (Italy)

^b SCUOLA NORMALE SUPERIORE   (Italy)

Author keywords

Glutamate; Hippocampus; Neurotransmitter release; Seizures

Indexed keywords

ANTICONVULSIVE AGENT; BOTULINUM TOXIN; NEUROTOXIN;

ANIMAL; CENTRAL NERVOUS SYSTEM; DRUG EFFECT; ELECTROPHYSIOLOGY; HUMAN; NERVE CELL; REVIEW;

ANIMALS; ANTICONVULSANTS; BOTULINUM TOXINS; CENTRAL NERVOUS SYSTEM; ELECTROPHYSIOLOGY; HUMANS; NEURONS; NEUROTOXINS;

EID: 33747185889     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03033939     Document Type: Article

References (52)

1. Ando S, S Kobayashi, H Waki, K Kon, F Fukui, T Tadenuma, M Iwamoto, Y Takeda, N Izumiyama, K Watanabe and H Nakamura (2002) Animal model of dementia induced by entorhinal synaptic damage and partial restoration of cognitive deficits by BDNF and carnitine. J. Neurosci. Res. 70, 519-527.
2. Ashton AC and JO Dolly (1988) Characterization of the inhibitory action of botulinum neurotoxin type A on the release of several transmitters from rat cerebrocortical synaptosomes. J. Neurochem. 50, 1808-1816.
3. Ashton AC and JO Dolly (1991) Microtubule-dissociating drugs and A23187 reveal differences in the inhibition of synaptosomal transmitter release by botulinum neurotoxins types A and B. J. Neurochem. 56, 827-835.
4. 2+] i is not blocked by Clostridial neurotoxins. J. Neurochem. 74, 1979-1988.
5. Bergquist F, HS Niazi and H Nissbrandt (2002) Evidence for different exocytosis pathways in dendritic and terminal dopamine release in vivo. Brain Res. 950(1-2), 245-253.
6. Berliocchi L, E Fava, M Leist, V Horvat, D Dinsdale, D Read and P Nicotera (2005) Botulinum neurotoxin C initiates two different programs for neurite degeneration and neuronal apoptosis. J. Cell Biol. 168(4), 607-618.
7. Bigalke H, G Ahnert-Hilger and E Habermann (1981a) Tetanus toxin and botulinum toxin A inhibit acetylcholine release from but not calcium uptake into brain tissue. Naunyn Schmiedebergs Arch. Pharmacol. 316, 143-148.
8. Bigalke H, I Heller, B Bizzini and E Habermann (1981b) Tetanus toxin and botulinum A toxin inhibit release and uptake of various transmitters, as studied with particulate preparations from rat brain and spinal cord. Naunyn Schmiedebergs Arch. Pharmacol. 316, 244-251.
9. Bigalke H, F Dreyer and G Bergey (1985) Botulinum A neurotoxin inhibits non-cholinergic synaptic transmission in mouse spinal cord neurons in culture. Brain Res. 360, 318-324.
10. Capogna M, BH Gahwiler and SM Thompson (1996) Calcium-independent actions of alpha-latrotoxin on spontaneous and evoked synaptic transmission in the hippocampus. J. Neurophysiol. 76, 3149-3158.
11. 2+ partially rescues synaptic transmission in hippocampal cultures treated with botulinum toxin A and C, but not tetanus toxin. J. Neurosci. 17, 7190-7202.
12. Cohen I, V Navarro, S Clemenceau, S Baulac and R Miles (2002) On the origin of interictal activity in human temporal lobe epilepsy in vitro. Science 298, 1418-1421.
13. Costantin L, Y Bozzi, C Richichi, A Viegi, F Antonucci, M Funicello, M Gobbi, T Mennini, O Rossetto, C Montecucco, L Maffei, A Vezzani and M Caleo (2005) Antiepileptic effects of botulinum neurotoxin E. J. Neurosci. 25, 1943-1951.
14. Dolly JO, RS Williams, JD Black, CK Tse, P Hambleton and J Melling (1982) Localization of sites for 125 I-labelled botulinum neurotoxin at murine neuromuscular junction and its binding to rat brain synaptosomes. Toxicon 20, 141-148.
15. Engel J (1996) Introduction to temporal lobe epilepsy. Epilepsy Res. 26, 141-150. Review.
16. Fassio A, R Sala, G Bonanno, M Marchi and M Raiteri (1999) Evidence for calcium-dependent vesicular transmitter release insensitive to tetanus toxin and botulinum toxin type F. Neuroscience 90, 893-902.
17. Foran PG, N Mohammed, GO Lisk, S Nagwaney, GW Lawrence, E Johnson, L Smith, KR Aoki and JO Dolly (2003) Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neurons. J. Biol. Chem. 278, 1363-1371.
18. Gilio F, A Currà, C Lorenzano, N Modugno, M Manfredi and A Berardelli (2000) Effects of botulinum toxin type A on intracorti-cal inhibition in patients with distonia. Ann. Neurol. 48, 20-26.
19. Grosse G, J Grosse, R Tapp, J Kuchinke, M Gorsleben, I Fetter, B Hohne-Zell, M Gratzl and M Bergmann (1999) SNAP-25 requirement for dendritic growth of hippocampal neurons. J. Neurosci. Res. 56, 539-546.
20. Holmes GL (2002) Seizure-induced neuronal injury: Animal data. Neurology 59, S3-S6. Review.
21. Hou Q, X Gao, X Zhang, L Kong, X Wang, W Bian, Y Tu, M Jin, G Zhao, B Li, N Jing and L Yu (2004) SNAP-25 in hippocampal CA1 region is involved in memory consolidation. Eur. J. Neurosci. 20(6), 1593-1603.
22. Kawakami M, M Sekiguchi, K Sato, S Kozaki and M Takahashi (2001) Erythropoietin receptor-mediated inhibition of exocytotic glutamate release confers neuroprotection during chemical ischemia. J. Biol. Chem. 276, 39469-39475.
23. Keller JE, E Neale, G Oyler and M Adler (1999) Persistence of botulinum neurotoxin action in cultured spinal cord cells. FEBS Lett. 456, 137-142.
24. Keller JE and EA Neale (2001) The role of the synaptic protein SNAP-25 in the potency of botulinum neurotoxin type A. J. Biol. Chem. 276(16), 13476-13482.
25. Lalli G, S Bohnert, K Deinhardt, C Verastegui and G Schiavo (2003) The journey of tetanus and botulinum toxins in neurons. Trends Microbiol. 11(9), 431-437. Review.
26. Luvisetto S, O Rossetto, C Montecucco and F Pavone (2003) Toxicity of botulinum neurotoxins in central nervous system of mice. Toxicon 41(4), 475-481.
27. Luvisetto S, S Marinelli, O Rossetto, C Montecucco and F Pavone (2004) Central injection of botulinum neurotoxins: Behavioural effects in mice. Behav. Pharmacol. 15(3), 233-240.
28. McMahon HT, P Foran, JO Dolly, M Verhage, VM Wiegant and DG Nicholls (1992) Tetanus toxin and botulinum toxins type A and B inhibit glutamate, gamma-aminobutyric acid, aspartate, and met-enkephalin release from synaptosomes. Clues to the locus of action. J. Biol. Chem. 267, 21338-21343.
29. Meldrum BS (1995) Excitatory amino acid receptors and their role in epilepsy and cerebral ischemia. Ann. NYAcad. Sci. 757, 492-505. Review.
30. Meunier FA, G Schiavo and J Molgo (2002) Botulinum neurotoxins: From paralysis to recovery of functional neuromuscular transmission. J. Physiol. Paris 96, 105-113. Review.
31. Montecucco A and J Molgo (2005) Botulinal neurotoxins: Revival of an old killer. Curr. Op. Pharmacol. 5, 274-279. Review.
32. Murakami T, M Okada, Y Kawata, G Zhu, A Kamata and S Kaneko (2001) Determination of effects of antiepileptic drugs on SNAREs-mediated hippocampal monoamine release using in vivo microdialysis. Br. J. Pharmacol. 134(3), 507-520.
33. Nakov R, E Habermann, G Hertting, S Wurster and C Allgaier (1989) Effects of botulinum A toxin on presynaptic modulation of evoked transmitter release. Eur. J. Pharmacol. 164, 45-53.
34. Neale EA, LM Bowers, M Jia, KE Bateman and LC Williamson (1999) Botulinum neurotoxin A blocks synaptic vesicle exocytosis but not endocytosis at the nerve terminal. J. Cell Biol. 147(6), 1249-1260.
35. Okada M, DJ Nutt, T Murakami, G Zhu, A Kamata, Y Kawata and S Kaneko (2001) Adenosine receptor subtypes modulate two major functional pathways for hippocampal serotonin release. J. Neurosci. 21, 628-640.
36. Osen-Sand A, JK Staple, E Naldi, G Schiavo, O Rossetto, S Petitpierre, A Malgaroli, C Montecucco and S Catsicas (1996) Common and distinct fusion proteins in axonal growth and transmitter release. J. Comp. Neurol. 367, 222-234.
37. Otto H, PI Hanson, ER Chapman, J Blasi and R Jahn (1995) Poisoning by botulinum neurotoxin A does not inhibit formation or disassembly of the synaptosomal fusion complex. Biochem. Biophys. Res. Commun. 212, 945-952.
38. Owe-Larsson B, K Kristensson, RH Hill and L Brodin (1997) Distinct effects of clostridial toxins on activity-dependent modulation of autaptic responses in cultured hippocampal neurons. Eur. J. Neurosci. 9, 1773-1777.
39. Regesta G and P Tanganelli (1999) Clinical aspects and biological bases of drug-resistant epilepsies. Epilepsy Res. 34, 109-122. Review.
40. Rossetto O, M Severo, P Caccin, G Schiavo and C Montecucco (2001) Tetanus and botulinum neurotoxins: Turning bad guys into good by research. Toxicon 39, 27-41. Review.
41. Sanchez-Prieto J, TS Sihra, D Evans, A Ashton, JO Dolly and DG Nicholls (1987) Botulinum toxin A blocks glutamate exocytosis from guinea-pig cerebral cortical synaptosomes. Eur. J. Biochem. 165, 675-681.
42. Schiavo G, M Matteoli and C Montecucco (2000) Neurotoxins affecting neuroexocytosis. Physiol. Rev. 80, 717-766. Review.
43. Spencer SS (2002) When should temporal-lobe epilepsy be treated surgically? Lancet Neurol. 1, 375-382. Review.
44. Stables JP, E Bertram, FE Dudek, G Holmes, G Mathern, A Pitkanen and HS White (2003) Therapy discovery for pharmacoresistant epilepsy and for disease-modifying therapeutics: Summary of the NIH/NINDS/AES models II workshop. Epilepsia 44, 1472-1478. Review.
45. Stigliani S, L Raiteri, A Fassio and G Bonanno (2003) The sensitivity of catecholamine release to botulinum toxin C1 and E suggests selective targeting of vesicles set into the readily releasable pool. J. Neurochem. 85(2), 409-421.
46. Sutton MA, NR Wall, GN Aakalu and EM Schuman (2004) Regulation of dendritic protein synthesis by miniature synaptic events. Science 304, 1979-1983.
47. Takei N, T Numakawa, S Kozaki, N Sakai, Y Endo, M Takahashi and H Hatanaka (1998) Brain-derived neurotrophic factor induces rapid and transient release of glutamate through the non-exo-cytotic pathway from cortical neurons. J. Biol. Chem. 273(42), 27620-27624.
48. Trudeau LE, Y Fang and PG Haydon (1998) Modulation of an early step in the secretory machinery in hippocampal nerve terminals. Proc. Natl. Acad. Sci. USA 95, 7163-7168.
49. Turton K, JA Chaddock and KR Acharya (2002) Botulinum and tetanus neurotoxins: Structure, function and therapeutic utility. Trends Biochem. Sci. 27, 552-557. Review.
50. Verderio C, S Coco, O Rossetto, C Montecucco and M Matteoli (1999) Internalization and proteolytic action of botulinum toxins in CNS neurons and astrocytes. J. Neurochem. 73, 372-379.
51. Verderio C, D Pozzi, E Pravettoni, F Inverardi, U Schenk, S Coco, V Proux-Gillardeaux, T Galli, O Rossetto, C Frassoni and M Matteoli (2004) SNAP-25 modulation of calcium dynamics underlies differences in GABAergic and glutamatergic responsiveness to depolarization. Neuron 41, 599-610.
52. Williamson LC, JL Halpern, C Montecucco, JE Brown and EA Neale (1996) Clostridial neurotoxins and substrate proteolysis in intact neurons. Botulinum neurotoxin C acts on synaptosomal-associated protein of 25 kDa. J. Biol. Chem. 271, 7694-7699.